News
An Aiims study suggests lymph node removal after chemotherapy may improve survival in advanced ovarian cancer patients, ...
Uterine cancer affects 28 in 100,000 women annually. Learn the 5 critical warning signs that could save your life and why ...
Hosted on MSN27d
“How I Knew I Had Ovarian Cancer”: A Patient’s Story Reveals an Unexpected Benefit of Daily ExerciseThere are the types of cancer you can screen for—like breast ... My doctor ordered a transvaginal ultrasound, but that test came back clear too. Everything escalated in August of 2022.
“How I Knew I Had Ovarian Cancer”: A Patient’s Story Reveals an Unexpected Benefit of Daily Exercise
"Here's How I Knew I Had Uterine Cancer": One Patient's Story After Spotting a Tell ... At my annual gynecologist appointment, I brought it up. My doctor ordered a transvaginal ultrasound, but that ...
Even though the lack of periods may seem convenient, sustained lengths of time without a period may increase your risk of endometrial cancer. Your healthcare ... prolactin), perform a transvaginal ...
Ovarian cancer, historically challenging to diagnose due to vague early symptoms, often reaches advanced stages before detection. Risk factors include age, obesity, genetics, and hormone therapy.
New research has revealed how a novel IgE antibody (MOv18) therapy reactivates the immune cells of ovarian cancer patients, enabling them to fight the disease more effectively. Conducted by ...
Current CA-125 thresholds may miss ovarian cancer in racially diverse patients, delaying treatment initiation and contributing to health disparities. Original CA-125 studies were conducted on ...
Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer. Rinatabart sesutecan (Rina-S) is an antibody-drug conjugate that targets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results